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Abstract
The development of tolerance to a drug at the level of the neuron reflects a homeostatic mechanism by which neurons
respond to perturbations of their function by external stimuli. Acute functional tolerance (AFT) to ethanol is a fast
compensatory response that develops within a single drug session and normalizes neuronal function despite the continued
presence of the drug. We performed a genetic screen to identify genes required for the development of acute functional
tolerance to ethanol in the nematode C. elegans. We identified mutations affecting multiple genes in a genetic pathway
known to regulate levels of triacylglycerols (TAGs) via the lipase LIPS-7, indicating that there is an important role for TAGs in
the development of tolerance. Genetic manipulation of lips-7 expression, up or down, produced opposing effects on
ethanol sensitivity and on the rate of development of AFT. Further, decreasing cholesterol levels through environmental
manipulation mirrored the effects of decreased TAG levels. Finally, we found that genetic alterations in the levels of the TAG
lipase LIPS-7 can modify the phenotype of gain-of-function mutations in the ethanol-inducible ion channel SLO-1, the
voltage- and calcium-sensitive BK channel. This study demonstrates that the lipid milieu modulates neuronal responses to
ethanol that include initial sensitivity and the development of acute tolerance. These results lend new insight into studies of
alcohol dependence, and suggest a model in which TAG levels are important for the development of AFT through
alterations of the action of ethanol on membrane proteins.
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Introduction
Alcohol abuse is a prevalent and serious disorder. Current drug
treatments are inadequate, in part because the molecular nature of
acute ethanol response is not well understood. A component of the
ethanol response in humans that is predictive of the susceptibility
to abuse alcohol is an individual’s naı¨ve level of response to the
drug [1], and this phenotype is strongly genetically influenced
[2,3]. This level of response to ethanol consists of at least two
components, initial sensitivity and the development of acute
functional tolerance (AFT). Initial sensitivity is measured during
the onset of intoxication. In the nematode, C. elegans, we observe
initial sensitivity at 10 minutes of ethanol exposure. AFT reflects a
homeostatic mechanism of the nervous system to rapidly adapt to
the intoxicating effects of ethanol that is not a result of ethanol
metabolism. In mammals, AFT is observed during a single drug
exposure and is measured as a greater behavioral impairment at
the beginning of a drinking session than the impairment observed
at a similar blood ethanol concentration during the falling phase of
blood alcohol concentration. In C. elegans, we observe AFT during
a single ethanol exposure, in which the animals recover their
ability to move despite no decrease in internal ethanol concen-
tration [4].
Several proteins and pathways have been described that modify
the development of acute functional tolerance in different species.
GABAA receptors isolated from ethanol-treated mice demonstrate
acute tolerance in vitro [5], and this requires functional Protein
Kinase Ce. In addition, Protein Kinase Ce knock out mice show
defects in AFT [6]. In C. elegans, we have previously shown that the
Neuropeptide Y Receptor-like protein, NPR-1, acts to negatively
regulate the development of acute functional tolerance. This
observation extends to the mouse, where animals with loss of
function of various components of the brain NPY pathway recover
more rapidly from hypnotic doses of ethanol [7,8], a measure of
the development of AFT in mice [9].
Much work has focused on the effects of ethanol on protein
targets, and several excellent candidates for ethanol effector
molecules have been identified [10,11]. As the dominant theory
for many years, the lipid fluidity hypothesis of ethanol intoxication
proposed an indirect effect of ethanol on membrane proteins via
perturbation of membrane lipid structure [12,13]. While this
theory has fallen out of favor for several reasons, including the
observation of direct actions of ethanol on proteins, the relevance
of lipid-protein interactions in modulating protein function and in
modulating direct ethanol-protein effects are increasingly a target
of study [14–17].
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This study is designed to identify the molecular mechanisms for
the development of AFT. Here, we report that an unbiased genetic
screen for modulators of the development of AFT yielded genes
involved in determining levels of triacylglycerols in the animal.
Our data support a conclusion that the lipid environment is
important in the ability of the animal to modify cell function in the
development of AFT to ethanol.
Results
Isolation of Mutants Defective in Acute Functional
Tolerance
In order to identify the molecular mechanisms underlying acute
functional tolerance (AFT) to ethanol, we performed an unbiased
genetic screen for animals that are impaired in the ability to
develop AFT. We have previously shown that NPR-1 activity
antagonizes the development of AFT; in an npr-1 mutant
background, AFT develops more quickly than in wild type,
suggesting that NPR-1 function acts to slow the development of
AFT [4]. We took advantage of this phenotype of fast and obvious
development of AFT in the npr-1 mutant background to sensitize
our screen to make it easy to identify animals with diminished
AFT. The advantage of using this sensitized background is that we
should be able to identify mutations in which AFT is diminished
but not completely abolished, which would be difficult in the N2
wild-type background.
We performed EMS mutagenesis on npr-1(ky13) animals, and
subjected their F2 progeny to a behavioral screen. We treated the
animals with ethanol, allowed them time to develop AFT, and
then identified animals that had not developed tolerance using a
locomotion assay in which animals that could not develop
tolerance would be too impaired by ethanol to crawl to an
attractive odorant. We isolated animals that had not developed
tolerance, allowed them to produce self-progeny, and retested
their progeny in a quantitative assay of basal activity and ethanol
responses that measured both initial sensitivity and the develop-
ment of AFT. In this secondary assay, we placed worms on plates
that were contained 0 mM or 400 mM of ethanol. Movies were
recorded of locomotion at 10 and 30 minutes of treatment, and
speed was determined by computer analysis of the movies. We
define the decrease in speed at 10 minutes of treatment, relative to
untreated animals of the same genotype, as the initial sensitivity of
animals to ethanol. We have previously shown that wild-type
worms move faster at 30 minutes relative to their speed at 10
minutes of ethanol exposure, and we consider the amount of
recovery of speed between 10 and 30 minutes to be the degree of
acute functional tolerance. We judged animals to be defective in
AFT if they had a reduced recovery of speed at 30 minutes versus
the genetic background strain (npr-1(ky13) or N2).
We tested approximately 2600 mutagenized haploid genomes,
and recovered 16 recessive mutations that blunted the develop-
ment of AFT in the npr-1(ky13) mutant background, these identify
14 complementation groups. We pursued molecular characteriza-
tion of the mutation eg613 first because of its robust phenotype
(Figure 1a).
Identification of ctbp-1 as a Mediator of AFT
The eg613 mutation was mapped to the left arm of the X
chromosome using SNP mapping methods with the polymorphic
wild strain, CB4856 [18,19]. Using transformation rescue
experiments we identified the gene affected by mutation in the
eg613 mutant strain as ctbp-1. We found that the eg613 mutation is
a splice site mutation in the last nucleotide of intron 9 in the open
reading frame of the gene ctbp-1 that is predicted to generate a
premature stop codon that results in a truncated protein. A
deletion allele of ctbp-1, ok498, failed to complement eg613 for the
AFT phenotype, and homozygous ctbp-1(ok498) animals phe-
nocopied eg613 mutants by suppressing the fast development of
AFT of npr-1(ky13), tested in a visual assay of speed on ethanol,
indicating that ctbp-1 is disrupted by the eg613 mutation. The
CTBP-1 protein contains a DNA-binding THAP domain, and
Figure 1. The transcriptional regulators CTBP-1 and PAG-3 are
required for the development of AFT. Animals were treated with
0 mM and 400 mM exogenous ethanol. Relative speeds were calculated
as treated over untreated speeds. Animals shown in the same graph
were tested simultaneously on the same plates. a) Wild-type N2 animals
develop AFT, and npr-1(ky13) animals are significantly faster developers
of AFT. Compared with npr-1(ky13), npr-1(ky13) ctbp-1(eg613) animals
have decreased initial sensitivity to ethanol; the decrease in develop-
ment of AFT was not significantly different from npr-1(ky13). ctbp-
1(eg613) animals in an npr-1(+) (N2) background develop significantly
less AFT than N2 (n=22). b) PAG-3 is required for the development of
AFT. pag-3(n3098) animals do not develop AFT, and when tested in the
sensitized background, pag-3(n3098) npr-1(ky13) animals have de-
creased initial sensitivity and are slow developers of AFT compared
with npr-1(ky13) (n=13). Note that the large decrease in speed in pag-
3(n3098) animals at 30 minutes of ethanol exposure is largely driven by
an increase in their untreated speed at 30 minutes, and may not reflect
an actual increase in sensitivity to ethanol during that interval. We have
not observed this kind of increase in untreated speed in other strains of
animals tested, including in the npr-1(ky13) pag-3(n3098) double
mutant. pag-3(n3098) animals do not increase their speed on ethanol
over the course of 30 minutes, indicating that they are defective in AFT
(at 400 mM: 10 minutes = 32.4 6 2.6 mm/sec, 30 minutes = 33.7 6
1.3 mm/sec; not significantly different t40 = 0.42, P = 0.67). Error bars
are s.e.m. For indicated comparisons: n.s., not significant; *, P , 0.05; **,
P, 0.01; ***, P, 0.001; for comparison to N2 at 10 minutes:###, P,
0.001; for comparison to npr-1(ky13) at 10 minutes: {, P , 0.05; {{, P ,
0.01; {{{, P , 0.001.
doi:10.1371/journal.pone.0035192.g001
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CTBP-1 has been shown to act as a negative regulator of
transcription [20].
In order to determine if ctbp-1(eg613) is dependent on a loss of
npr-1 function to modify AFT, we crossed the mutation away from
the npr-1(ky13) mutation and tested its ability to develop acute
tolerance in the presence of wild-type npr-1. When we examined
the development of AFT in animals carrying the ctbp-1(eg613)
mutation alone, we found that they had reduced AFT compared
with N2 animals (Figure 1a), demonstrating that ctbp-1 is a
component that is generally required for the development of AFT,
independent of the genetic background.
The transcriptional regulator sir-2.1 acts genetically upstream to
repress function of ctbp-1 [21]; we predicted that in a sir-2.1 mutant
strain, loss of negative regulation of ctbp-1 might result in fast
development of AFT. We found that sir-2.1 mutant animals were
resistant to ethanol relative to N2, and, while there was a trend
toward fast development of AFT, there was not a statistical
difference in rate of AFT from N2 (Figure 2). Together, these
results suggest that ctbp-1 is a regulator of AFT.
pag-3 is Required for AFT and pag-3 was Isolated in the
Screen
The transcription factor CTBP-1 has been shown to bind to
and act with the zinc-finger transcription factors PAG-3 and
ZAG-1 to repress transcription of target genes [20]. We reasoned
that if ctbp-1 mutant animals are defective in AFT because of loss
of transcriptional regulation of some effector genes that are
cooperatively regulated by these co-repressors, then animals
defective in either of the other two co-repressors should also be
defective in AFT. Animals mutant in either pag-3 or zag-1 have
locomotion defects; we were unable to test zag-1 mutants in our
behavioral assays because they are too uncoordinated to allow us
to distinguish between locomotion defects induced by ethanol
and their baseline uncoordination. The more extreme phenotype
of the zag-1 and pag-3 mutants compared with ctbp-1 mutants
suggests that those genes have functions in addition to their
cooperative role with ctbp-1. While pag-3 mutant animals are also
uncoordinated, their locomotion defect is less severe, and we
were able to assess them for the development of AFT. We found
that the loss-of-function allele pag-3(n3098) did not develop AFT,
and it also suppressed the fast development of AFT of npr-1(ky13)
(Figure 1b), suggesting that ctbp-1(eg613) is defective in AFT
because it fails to regulate transcription, and that this function of
ctbp-1 requires pag-3. Since a mutation in pag-3 was able to
suppress the npr-1-mediated fast development of AFT, we
reasoned that our genetic screen may have identified an allele
of pag-3. Another mutation isolated in our screen, bet16, mapped
to the genetic interval containing pag-3 and failed to complement
four alleles of pag-3 for the AFT phenotype, as tested in visual
assays of speed on ethanol. These results indicate that this
behavioral screen identified multiple members of a molecular
pathway that is involved in the development of AFT.
Dysregulation of ida-19s Control of Neurosecretion is not
Responsible for the AFT Phenotypes of ctbp-1
We were interested in determining which genes that are
regulated by ctbp-1 and pag-3 are responsible for the defect in
AFT that we observed in those animals. To date, in C. elegans,
the only specific regulatory target of pag-3 that has been reported
is the gene ida-1, which encodes a protein involved in dense core
vesicle release. The loss of negative regulation of ida-1 in pag-3
mutants causes increased neurosecretion [22]. We would expect
any gene that is important for the shared AFT phenotype in pag-
3 and ctbp-1 to also be misregulated in the ctbp-1 mutant. Chen
et al. [21] performed microarray analysis of a ctbp-1 mutant, and
reported genes with expression differences of 2-fold or more from
wild type, and while expression of ida-1 was not reported to be
altered in this study, it remained possible that a more subtle
transcriptional dysregulation, which did not meet the criteria for
inclusion in that report, may be functionally relevant in the
development of AFT. Therefore, we tested whether altering ida-1
function could be an explanation for the altered rate of
development of AFT in ctbp-1 and pag-3. We found that the
response of the strong loss-of-function ida-1(ok409) mutant
animals to ethanol was indistinguishable from that of N2
(Table 1), suggesting that a change in the rate of neurosecretion
is not the explanation for the AFT phenotype of animals carrying
mutations in these transcriptional regulators. As noted above, we
have further observed that pag-3 mutant animals are mildly
uncoordinated, while ctbp-1 mutants are not, suggesting that this
transcriptional repressor may regulate expression of a larger
group of genes than those that overlap with ctbp-1, and ida-1 may
be in that class of differentially regulated genes.
ctbp-1 Regulates AFT through Repression of lips-7
Expression
CTBP-1 has been demonstrated to regulate the transcription of
approximately 200 genes [21]. Chen et al [21] reported that ctpb-
1(ok498) mutants have an extended lifespan, and that the loss of
regulation of the lips-7 triacylglycerol (TAG) lipase in the ctbp-1
mutant could explain this aspect of the ctbp-1 mutant phenotype.
In ctbp-1(ok498) mutant animals, lips-7 message is increased, and
the resulting lipase overexpression caused animals to accumulate
16.8% less TAGs, and animals in which lips-7 had been
inactivated by RNA interference had dramatically increased levels
of TAGs [21]. We hypothesized that if the effect of loss of function
of ctbp-1 on ethanol response, like its effect on lifespan, is due to its
Figure 2. The ctbp-1-regulated gene lips-7modulates the rate of
the development of AFT. Animals were tested on 0 mM and
400 mM exogenous ethanol. Relative speeds were calculated as treated
over untreated speeds. All animals were tested simultaneously on the
same plates. a) lips-7(ok3110) animals are resistant to ethanol at 10
minutes of exposure relative to wild-type N2, and they develop
significantly more AFT than wild-type N2 animals (n= 13). b) The
transcription factor sir-2.1 is a negative regulator that acts genetically
upstream of ctbp-1 [21]; in a sir-2.1 mutant strain, loss of negative
regulation of ctbp-1 should result in fast development of AFT.
Compared with N2, sir-2.1(ok434) mutant animals were resistant to
ethanol at 10 minutes of exposure but their apparent increase in
development of AFT did not reach statistical significance (n= 13). Error
bars are s.e.m. For indicated comparisons: n.s., not significant; *, P ,
0.05; ***, P , 0.001; for comparison to N2 at 10 minutes: ###, P ,
0.001.
doi:10.1371/journal.pone.0035192.g002
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Table 1. Mutants tested for initial sensitivity and development of acute functional tolerance to ethanol.
GENE PROTEIN
PHENOTYPE of
LOSS-of-FUNCTION INITIAL SENSITIVITYa DEVELOPMENT OF AFTb
ida-1(ok409) [22] Protein tyrosine
phosphatase-like receptor
Increase in
neurosecretionc
Not different from N2 Not different from N2
N2 (109) : 28.1 6 2.4% N2 (309): 36.4 6 2.3%
ok409 (109): 32.1 6 2.1% recovery (309-109): 8.3 6 2.3%
t6 = 1.66, P = 0.15 ok409 (309): 41.8 6 1.9%
recovery (309-109): 9.7 6 1.9%
t6 = 0.49, P = 0.64
nhr-49(ok2165) and
nhr-49(gk405) [40]
Nuclear hormone
receptor
Increase in fat storaged Not different from N2 No development of AFT
N2 (109): 30.3 6 1.4% N2 (309): 34.8 6 3.3%
ok2165 (109): 30.3 6 3.0% recovery (309-109): 4.5 6 3.7%
t7 = 0.002, P = 0.99 ok2165 (309): 28.0 6 3.2%
N2 (109): 34.9 6 2.6% recovery (309-109): -2.3 6 1.4%
gk405 (109): 38.8 6 3.7% N2 (309): 47 6 4.0%
t6 = 0.97, P = 0.37 recovery (309-109): 11.7 6 2.5%
gk405 (309): 38.6 6 3.8%
recovery (309-109): -0.2 6 3.1%
bbs-1(ok1111) [41] Ortholog to human BBS1 Increase in fat storaged More sensitive than N2 Faster development of AFT relative to N2
N2 (109): 31.4 6 3.4% N2 (309): 43.1 6 2.1%
ok1111 (109): 15.2 6 0.95% recovery (309-109): 11.7 6 2.5%
t8 = 4.5, P ,0.01 ok1111 (309): 32.0 6 2.1%
recovery (309-109): 16.7 6 2.0%
t8 = 2.9, P , 0.05
tub-1(ok1972) [42] tubby Increase in fat storaged Not different from N2 Not different from N2
N2 (109): 34.9 6 3.5% N2 (309): 48.9 6 2.9%
ok1972 (109): 28.3 6 2.5% recovery (309-109): 13.8 6 1.9%
t5 = 1.4, P = 0.21 ok1972 (309): 46.6 6 4.9%
recovery (309-109): 15.1 6 2.0%
t5 = 0.47, P = 0.65
fat-7(wa36); fat-5(tm420)
[43]
Fatty acid desaturases Decrease in fat storaged Not different from N2 Faster development of AFT relative to N2
N2 (109): 32.2 6 1.6% N2 (309): 35.3 6 3.2%
wa36;tm420 (109): 30.3 6 2.8% recovery (309-109): 6.5 6 1.6%
t11 = 0.80, P = 0.44 wa36;tm420 (309): 44.6 6 2.5%
recovery (309-109): 14.2 6 1.7%
t11 = 6.7, P , 0.0001
sbp-1(ep79) [44] Homolog to mammalian
SREBP
Decrease in fat storaged Less sensitive than N2 e No development of AFT
N2 (109): 32.4 6 2.6% N2 (309): 43.6 6 2.8%
ep79 (109): 45.9 6 4.2% recovery (309-109): 11.2 6 2.4%
t6 = 3.0, P , 0.05 ep79 (309): 37.9 6 5.5%
recovery (309-109): -8.0 6 8.5%
aThe degree of initial sensitivity was determined as the percent of untreated speed after 10 minutes of ethanol exposure. Significance was determined relative to the
effect of ethanol on wild-type N2 animals treated on the same plates using paired two-tailed t-tests. bThe development of acute functional tolerance (AFT) was
determined by comparing the rate of locomotion at 30 minutes vs. 10 minutes of ethanol exposure. If the mutant strain developed significant tolerance, we compared
its rate of development of tolerance to the rate of wild-type N2 animals treated on the same plates using unpaired two-tailed t-tests. cida-1 is known to be negatively
regulated by pag-3; the response of the strong loss of function ida-1(ok409) mutant animals to ethanol was indistinguishable from that of N2, suggesting that a change
in neurosecretion is not the explanation for the AFT phenotype of ctbp-1 and pag-3. dGenetic manipulation of fat stores by mutations in the genes nhr-49, bbs-1, tub-1,
fat-7 and fat-5, and sbp-1 did not alter ethanol sensitivity or AFT in a consistent manner, suggesting that fat levels themselves do not influence the rate of development
of AFT. esbp-1 mutant animals have a basal speed that is significantly slower than N2 (Table S1). For this reason, the magnitude and interpretation of the ethanol
responses of this strain may be subject to a floor effect.
doi:10.1371/journal.pone.0035192.t001
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failure to down-regulate lips-7, then loss of lips-7 should have the
opposite phenotype to loss of ctbp-1; that is, lips-7 mutants should
display ethanol resistance and/or fast development of AFT. We
found that lips-7(ok3110) mutant animals are both resistant to
ethanol and fast developers of AFT, indicating that regulation of
TAG levels is important for the development of AFT (Figure 2a).
These results support the notion that the effect on lipase regulation
via lips-7 is a mechanism of ctbp-19s effect on AFT (Figure 2b).
Fat Stores do not Regulate AFT
Regulation of the lipase gene lips-7 has a significant effect on the
development of AFT. In one model of how this lipase function
affects AFT, fat levels in the animals could regulate ethanol effects
because TAGs are the main stored fat in C. elegans. To test this
hypothesis, we altered fat levels in the animals using genetic
manipulations, and tested the effect on ethanol sensitivity and AFT
development in our locomotion assay. If the changes in the level of
stored fat in ctbp-1 and lips-7 mutants is the cause of the defect in
AFT, then decreasing fat levels through genetic manipulation
should cause a decrease in AFT (mimicking ctbp-1(eg613) mutants),
while increasing fat levels should cause animals to be resistant to
ethanol or fast developers of AFT (similar to lips-7 mutant
animals). We tested several genes involved in regulating the levels
of stored fat; mutations in these genes either yield increases or
decreases in stored fat (Table 1). While several changes in fat levels
did not cause an AFT phenotype, for those that did alter AFT,
there was no consistent correlation between fat levels and the
ability to develop AFT (Table 1). These data suggest that, by
themselves, levels of stored fat do not predict the ability of the
animal to develop AFT.
The Development of AFT is Cholesterol Dependent
In addition to their role in fat storage, TAGs are also
components of the lipid membrane. To analyze the involvement
of membrane environment in the development of AFT, we
manipulated the plasma membrane by depleting the worms of
cholesterol, a component of membrane lipid rafts [23]. C. elegans
are cholesterol auxotrophs; all of their cholesterol is captured
through their diet, and acute effects of cholesterol depletion
include a suppression of clathrin-independent endocytosis in
neurons, a lipid raft-mediated process [24], suggesting that
cholesterol is involved in the development or maintenance of
particular membrane structures. If AFT requires specific
membrane microdomain structures that include cholesterol, then
altering the amount of cholesterol available to the animals may
modify their ability to develop tolerance. We found that N2 and
npr-1(ky13) animals reared on cholesterol-depleted media dem-
onstrated a substantial suppression of the development of AFT
(Figure 3a and 3b). In contrast, adding additional cholesterol to
the medium did not affect the ability of animals to develop AFT
(not shown). Together, these data suggest that the structure of the
lipid bilayer is essential for the development of tolerance.
The Development of AFT Requires SLO-1
Both the manipulation of cholesterol and the lipid constituents
of the membrane environment are known to modulate the
ethanol effect on the mammalian BK (KCNMA1/Slo1) potas-
sium channel, an ethanol target protein[14,17,25–28]. In worms,
ethanol activates SLO-1 in vivo, causing a large efflux of
potassium ions, hyperpolarizing the cell and depressing neuronal
excitability, which is a major cause of intoxication in C. elegans
[29]. The mammalian BK channel is also activated by ethanol,
and this effect, as well as the channel’s basal activity, depends on
the thickness of the lipid bilayer; channels that reside in thicker
membrane are less basally active and are less activated by
ethanol [17,28], suggesting that movement of the BK channel
into and out of areas of thicker membrane microenvironments
may allow for very fast modulation of the effects of ethanol on
this channel [28]. We hypothesized that this may be one
mechanism by which worms develop AFT to ethanol. If AFT
requires modulation of SLO-1 function, then complete loss of
SLO-1 should reduce or eliminate the development of tolerance.
In an otherwise wild-type background, null slo-1(eg142) mutant
animals are quite resistant to the sedative effects of ethanol on
locomotion, and, importantly, do not develop significant toler-
ance to ethanol (Figure 4b). We asked if loss of slo-1 completely
eliminated the ability of animals to develop tolerance, even in a
genetic background of fast development of tolerance. In the
sensitized npr-1(ky13) mutant background, slo-1(eg142) animals,
that lack SLO-1, are able to develop a degree of tolerance
(Figure 4b), indicating that modulation of the ethanol effect on
SLO-1 occurs during AFT but that SLO-1 is not the sole
mediator of AFT.
Figure 3. Disruption of the plasma membrane through
cholesterol starvation eliminates the ability to develop AFT.
Worms require exogenous cholesterol for plasma membrane mediated
processes such as clathrin-independent endocytosis. Young adult
animals that were starved of exogenous cholesterol during their
development were tested on 0 mM and 400 mM ethanol. Relative
speeds were calculated as treated over untreated. Animals shown in the
same graph were tested simultaneously on the same plates. a) Wild-
type N2 animals develop AFT when reared on cholesterol-containing
(NGM) plates, but do not develop AFT when starved of cholesterol
(n= 14). b) npr-1(ky13) animals develop AFT when reared on NGM
plates, but develop reduced levels of AFT when starved of cholesterol
(n= 7). Together, these results suggest that the development of AFT
requires cholesterol in the membrane. Error bars are s.e.m. For indicated
comparisons: n.s., not significant; *, P , 0.05; **, P , 0.01; for
comparison to N2 on NGM at 10 minutes: ###, P , 0.001; for
comparison to npr-1(ky13) on NGM at 10 minutes: {, P , 0.05.
doi:10.1371/journal.pone.0035192.g003
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ctbp-1 and lips-7 Modulate the Function of SLO-1
If modulation of SLO-1 activity represents a significant
component of AFT then it is possible that the increased TAG
levels associated with loss of lips-7 or sir-2.1 function are acting to
either protect the SLO-1 protein from ethanol or are reducing
overall activity of the SLO-1 protein, or both. If the action of this
increase in TAGs is to reduce overall activity of SLO-1 then we
predicted that we should be able to observe an inhibitory effect on
SLO-1 function in the lips-7 and sir-2.1 mutants in the absence of
ethanol. Reduced SLO-1 function in the slo-1 mutant causes an
increase in the amplitude of the locomotion waveform (loopy
motion phenotype, Figure 4a), and we observed that both lips-7
and sir-2.1 mutants are loopy (Figure 4a). In contrast, we predicted
that in a ctbp-1 mutant, in which there is a decrease in TAGs, there
should be an increase in SLO-1 activation, which should lead to
the opposite phenotype, a flattened body waveform. Consistent
with the prediction, we found that ctbp-1 mutants are flat relative
to N2 (Figure 4a).
We were able to test more directly whether or not loss of lips-7 is
able to modulate the function of SLO-1 in the absence of ethanol,
using special alleles of slo-1. Two gain-of-function alleles of slo-1
that enhance the open probability and open time of the channel
have been described [29]. These animals have a slow locomotion
phenotype, which shares characteristics with the phenotype of
ethanol intoxication. We hypothesized that lips-7 might suppress
these gain-of-function defects if the increase in levels of TAGs
reduces the activity of the channel. We tested the locomotion of
slo-1(ky389gf); lips-7(ok3110) and slo-1(ky399gf); lips-7(ok3110)
animals and found that loss of lips-7 was able to significantly
rescue the locomotion defect of both slo-1 gain-of-function
mutations (Figure 4c). These data strongly suggest that changes
in TAG levels resulting from increased or decreased LIPS-7
activity are able to influence the activity of a transmembrane
protein (SLO-1) both in its basal state and in the presence of
ethanol.
Discussion
We have used a genetic screen for mutations that result in
defects in the development of AFT to identify two transcriptional
co-repressors, ctbp-1 and pag-3, that regulate the ability of animals
to develop AFT. Transcriptional repression of the lips-7 TAG
lipase is required for normal development of AFT, and loss of lips-
7 enhances the rate and degree of AFT, indicating that action of
Figure 4. SLO-1 protein function is modulated by lips-7 function. a) Representative micrographs of crawling C. elegans, when the animal’s
head is at the dorsal most point in the propagation of its waveform. Anterior is left, scale bar is 200 mm. Wild-type N2 demonstrates the normal
sinusoidal body posture of a crawling worm. slo-1(eg142), lips-7(ok3110), and sir-2.1(ok434) demonstrate a similar exaggerated, loopy, body posture. In
contrast, ctbp-1(eg613) has a flattened body posture. b) SLO-1 function is required for normal AFT. Worms were treated with 400 mM exogenous
ethanol. slo-1(eg142) null mutant animals do not develop significant AFT, whereas slo-1(eg142); npr-1(ky13) double mutants do develop tolerance. The
degree of recovered speed of slo-1(eg142); npr-1(ky13) did not achieve statistical significance compared with npr-1(ky13), although there was a strong
trend for an attenuated response compared with the robust development of AFT by npr-1(ky13) (n= 14). These data suggest that SLO-1 is not the sole
mediator of the development of AFT in the worm. c) Loss of lips-7 can modulate function of slo-1 gain-of-function alleles. slo-1(ky398gf) and slo-
1(ky399gf) mutations increase the open probability or open time of the SLO-1 channel, resulting in a slow locomotion phenotype [29]. Loss of lips-7
significantly suppresses the slow movement phenotype of both slo-1(gf) alleles in the absence of ethanol (n= 6 for slo-1(ky389gf); n=9 for slo-
1(ky399gf)) indicating that the increase in TAGs in lips-7 can cause a change in the function of the membrane channel, SLO-1. These results suggest
that lips-7 alters SLO-1 function through a plasma membrane mechanism. Error bars are s.e.m. For indicated comparisons: n.s., not significant; *, P ,
0.05; ***, P , 0.001; for comparison to N2: #, P , 0.05; ##, P , 0.01; ###, P , 0.001.
doi:10.1371/journal.pone.0035192.g004
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this lipase inhibits the development of AFT. One component of
the normal development of AFT appears to involve modulation of
the ethanol effect on the transmembrane ethanol target protein
SLO-1, and the function of SLO-1 gain-of-function mutations is
modulated by the action of lips-7, suggesting that there is a role for
TAGs in the regulation of SLO-1 function. Depletion of
cholesterol impaired the development of AFT and, while
cholesterol is used both as a component of the plasma membrane
and as a precursor to steroid synthesis in the worm, taken together,
these data suggest a role for membrane microdomain structure in
AFT.
These results lead us to propose a model for a mechanism for
fast adaptations associated with the development of AFT: the
effects of ethanol on a membrane protein, such as SLO-1, are
countered by moving the protein into or out of specific membrane
microdomains to achieve a more normal function of the neuron in
the presence of ethanol. In this model, cholesterol and the TAGs
on which LIPS-7 acts would constitute components of these
microdomains that reduce the ethanol effect on the target protein,
either by protecting the protein from ethanol or by changing the
protein’s activity in opposition to the ethanol effect. An increase in
the levels of these TAGs might lead to an increase in the size or
quantity of these protective microdomains, thereby increasing the
potential for minimizing ethanol’s effects on target proteins;
decreases in the level of these TAGs would have the opposite effect
on AFT. This model accounts for the altered rates and
development of AFT in mutants for the ctbp-1, pag-3 and lips-7
genes, which regulate levels of these TAGs in different directions.
While we favor a model of a direct effect of lipid microdomains
in modulation of SLO-1 activity, as is seen for mammalian SLO-
1/BK channels (reviewed by Treistman and Martin [30]), the data
presented here are also compatible with a model in which lipid
modulation of activity of neuronal function occurs independently
of SLO-1 function. For example, altering the level of TAGs might
increase the excitability of cholinergic motor neurons or decrease
the excitability of GABAergic motor neurons, both effects might
lead to a decreased ethanol response. Loss of lips-7 function, which
increases TAG levels, results in a loopy locomotion phenotype,
acute ethanol resistance and a more rapid development of AFT.
These phenotypes are consistent with an increase in the overall
excitability of the locomotor cholinergic circuitry. However, we
have shown previously with mutants that enhance the activity of
the cholinergic neurons, that the degree of neuronal excitability
and the degree of ethanol sensitivity are not well correlated [29].
Effects by TAGs in a SLO-1-dependent manner and general
neuronal excitability effects are not mutually exclusive models, and
in fact these two postulated lipid effects may act in concert to
modify ethanol response at the behavioral level.
While our results do not directly address the question of the
causative microdomains in the membrane, one obvious candidate
is the lipid raft, a cholesterol- and sphingomyelin-rich micro-
domain in the plasma membrane. We show that cholesterol
depletion results in a significant reduction in the development of
AFT. Mammalian SLO-1/BK function is known to be modulated
by the cholesterol environment in which it resides in the
membrane [14,25–27], and the mammalian BK channel is found
in lipid rafts [31]. Recent studies suggest that the modulation of
channel function by cholesterol is through a specific interaction
with a protein surface on the SLO-1/BK channel itself rather than
a secondary effect of cholesterol’s effect on lipid packing [25,27].
There is increasing awareness of the modulation of function of
membrane proteins by their interaction with lipids. This model of
proteins moving between different lipid microenvironments during
AFT might include the effects of ethanol on multiple ethanol
responsive proteins in addition to SLO-1. For instance, ethanol
treatment inhibits localization of the proteins Lck, ZAP70, LAT
and PLCc1 to lipid rafts in T lymphocytes [15]. Another
intriguing candidate for a protein whose function is may be
modulated by its location in rafts is H-ras, which is known to be
involved in the dynamic response of NMDA receptors to ethanol
[32]. In its inactive form, H-ras resides in lipid rafts, and when
activated, it must move out of rafts to efficiently activate its target
Raf [33].
Importantly, this mechanism of modulation of protein function
may reflect a more general process used in maintaining
homeostasis in neurons. The mechanisms of development of
AFT to ethanol are likely to represent processes that neurons use
to modulate their function in response to depressive stimuli in
general.
An individual’s level of response to ethanol is dependent on the
AFT process. We hypothesize that subtle alterations in plasma
membrane structure, perhaps through natural genetic variation in
the lipid metabolism machinery, could lead to differences in rates
of development of AFT between individuals, which may contrib-
ute to predisposition to alcohol dependence (AD) [1]. Additional
support for this hypothesis comes from the observation that
membranes isolated from the brains of rats selectively bred for
high and low ethanol sensitivity showed differences in their ethanol
responsive phenotypes as measured by both membrane protein
mobility and membrane thickness [34].
Recently, a human genome-wide association study of AD in an
Australian population identified a SNP in the human homolog of
ctbp-1, called CTBP2, as the marker with the most significant P
value for association with AD [35]. Significantly, the mammalian
CTBP2 protein also acts as a transcriptional repressor, and has
recently been shown to play a role in regulating genes with roles in
lipid metabolism in adipocytes [36]. Variation in the function of
this gene may have more general effects on lipid membrane
composition and could impact responses to alcohol. We suggest
that it may be fruitful to further examine genes involved in
cholesterol and lipid biosynthesis in vertebrate models and human
genetic association studies of alcohol dependence.
Materials and Methods
Worm Husbandry
C. elegans strains were maintained as described [37]. Strains used
in this study were: N2 (var. Bristol), AX201 npr-1(ky13), BZ613
ctbp-1(eg613) (46outcrossed), RB733 ctbp-1(ok498), BZ846 ctbp-
1(ok498); npr-1(ky13), MT8987 pag-3(n3098), JCB40 pag-3(n3098);
npr-1(ky13), JCB25 pag-3(bet16); npr-1(ky13) (16outcrossed),
VC226 ida-1(ok409), RB2287 lips-7(ok3110), VC199 sir-
2.1(ok434), RB1716 nhr-49(ok2165), VC870 nhr-49(gk405),
VC837 bbs-1(ok1111), RB1600 tub-1(ok1972), BX110 fat-7(wa36);
fat-5(tm420), CE541 sbp-1(ep79), BZ142 slo-1(eg142), JCB95 slo-
1(ky389) (16outcrossed), JCB96 lips-7(ok3110); slo-1(ky389), JCB97
slo-1(ky399) (16outcrossed), and JCB98 lips-7(ok3110); slo-
1(ky399).
Genetic Screen
npr-1(ky13) animals were mutagenized in 47 mM ethyl meth-
anesulfonate (EMS) for 4 hours. Second generation progeny were
screened for failure to develop AFT: Worms were incubated for 90
minutes in 300 mM ethanol in M9, then were placed on one side
of a 10 cm Petri plate filled with assay agar [38] and 300 mM
ethanol. Worms were enticed to move across the plate to a spot of
chemoattractant (1 mL of 1:200 benzaldehyde:ethanol). In these
conditions, all npr-1(ky13) animals are able to develop sufficient
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AFT to be able to move to the spot of chemoattractant. After 90
minutes, worms that had not reached the chemoattractant were
picked individually and allowed to generate self-progeny. These
progeny were tested in a secondary screen for the development of
AFT; animals that failed to develop AFT were kept.
Analysis of Speed
Speed was analyzed as described previously [4], with minor
modifications: Briefly, assay plates were dried for two hours at
37uC with lids off on the day of the assay. Copper rings were
melted into the surface of the plates, and two hours before the
beginning of the assay, ice-cold 100% ethanol was added to plates
to a final concentration in the agar of 0 mM or 400 mM. Age-
matched first day adult animals were acclimated to the lack of food
in the assay for a period of 30 minutes by moving them to
unseeded dried plates. Ten worms of each test strain were moved
into a copper ring on an assay plates and movies were recorded of
their movement at 10 and 30 minutes of exposure. Only strains
that were tested in the same assay on the same plates were
compared to each other. Movies were made on an Olympus SZX-
7 stereo microscope (magnification of 0.8x with a 0.5x objective to
make a large enough field of view) using a Retiga 4000R camera
(QImaging) and ImagePro Plus (6.2) (MediaCybernetics) software.
2-minute recordings (1 frame per second) were captured, and the
speed of each worm was tracked using ImagePro plus software and
an average speed for each group of 10 animals was calculated.
Assessment of Ethanol Response
We assess ethanol response in three ways:
1- Initial Sensitivity: We compare the degree of depression of
speed (relative speed) at 10 minutes to that of the control strain.
A statistical difference at this timepoint reflects a change in
initial sensitivity.
2- Development of Acute Functional Tolerance: We compare the
speed of a strain at 30 minutes versus 10 minutes to determine
if the strain had developed AFT. A statistically significant
increase in speed at 30 minutes vs. 10 minutes is AFT.
3- Comparison of AFT with the control strain: We compare the
amount of speed recovered versus the control strain. Statisti-
cally significant differences in the amount of recovered speed
reflects a difference in the degree of AFT.
Statistics
Animals that were compared were tested on the same plates
under identical conditions. Untreated and treated raw speeds are
shown in Table S1. Relative speeds (treated/untreated X 100) for
ethanol effects were calculated and used for all strains in statistical
comparisons. Statistics were performed using Prism 5.0 (Graph-
Pad). Comparisons of 10-minute treated speed, comparisons of
recovered speed (treated speed at 30 minutes minus treated speed
at 10 minutes), and comparison of untreated speed on NGM
versus cholesterol-depleted media were made using 1-way
ANOVA, with Tukey’s multiple comparison posthoc tests.
Development of AFT was tested by unpaired two-tailed t-test.
Cholesterol Starvation
Cholesterol-depleted media was prepared as described previ-
ously [39].
Supporting Information
Table S1 Comparison of untreated speeds and treated
speeds (400 mM ethanol) for strains in each experiment
used to calculate relative treated speeds. All strains were
compared with N2, except for Figure 1b and Figure 3b, where npr-
1(ky13) is the comparison strain. The data was analyzed using 2-
way repeated measures ANOVA. If the ANOVA was significant
for the strain comparison, Bonferroni multiple comparison post-
hoc tests were used to determine the significance of differences
between the test strain at 10 minutes and at 30 minutes of ethanol
exposure compared with the comparison strain.
(DOC)
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